Pliant Therapeutics (PLRX) Other Accumulated Expenses (2021 - 2025)
Historic Other Accumulated Expenses for Pliant Therapeutics (PLRX) over the last 5 years, with Q3 2025 value amounting to $7.8 million.
- Pliant Therapeutics' Other Accumulated Expenses fell 6621.5% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 6621.5%. This contributed to the annual value of $14.4 million for FY2024, which is 1530.99% up from last year.
- Pliant Therapeutics' Other Accumulated Expenses amounted to $7.8 million in Q3 2025, which was down 6621.5% from $10.8 million recorded in Q2 2025.
- In the past 5 years, Pliant Therapeutics' Other Accumulated Expenses registered a high of $23.0 million during Q3 2024, and its lowest value of $5.9 million during Q4 2021.
- Moreover, its 5-year median value for Other Accumulated Expenses was $14.4 million (2024), whereas its average is $14.0 million.
- Per our database at Business Quant, Pliant Therapeutics' Other Accumulated Expenses soared by 9117.25% in 2022 and then plummeted by 6621.5% in 2025.
- Over the past 5 years, Pliant Therapeutics' Other Accumulated Expenses (Quarter) stood at $5.9 million in 2021, then skyrocketed by 91.17% to $11.2 million in 2022, then grew by 11.04% to $12.5 million in 2023, then rose by 15.31% to $14.4 million in 2024, then crashed by 45.84% to $7.8 million in 2025.
- Its Other Accumulated Expenses was $7.8 million in Q3 2025, compared to $10.8 million in Q2 2025 and $14.4 million in Q1 2025.